Xiaomin M. Luo

Guangzhou, 510006, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Fabrication and Characterization of Zein/Sodium Alginate Nanoparticles Loaded with Oxyresveratrol: Formation Mechanism, Molecular Dynamics Insights, and In Vitro Antioxidant Capacity.

Fabrication and Characterization of Zein/Sodium Alginate Nanoparticles Loaded with Oxyresveratrol: Formation Mechanism, Molecular Dynamics Insights, and In Vitro Antioxidant Capacity.

Journal: Micromachines

Published: April 10, 2026

Modular PROTAC/IMiD Bifunctional Molecule Design for the Degradation of Synergistic Targets in the Treatment of Lymphoma.

Modular PROTAC/IMiD Bifunctional Molecule Design for the Degradation of Synergistic Targets in the Treatment of Lymphoma.

Journal: Journal of medicinal chemistry

Published: October 14, 2025

Erratum: The inhibition of YTHDF3/m6A/LRP6 reprograms fatty acid metabolism and suppresses lymph node metastasis in cervical cancer: Erratum.

Erratum: The inhibition of YTHDF3/m6A/LRP6 reprograms fatty acid metabolism and suppresses lymph node metastasis in cervical cancer: Erratum.

Journal: International journal of biological sciences

Published: June 16, 2025

Exogenous Epstein-Barr virus nuclear antigen 1 induces ADAR1-driven tumor resistance against immunotherapy.

Exogenous Epstein-Barr virus nuclear antigen 1 induces ADAR1-driven tumor resistance against immunotherapy.

Journal: Signal transduction and targeted therapy

Published: June 12, 2025

Discovery of PVD-06 as a Subtype-Selective and Efficient PTPN2 Degrader.

Discovery of PVD-06 as a Subtype-Selective and Efficient PTPN2 Degrader.

Journal: Journal of medicinal chemistry

Published: November 15, 2023

Corrigendum: In vitro and in vivo antitumor activity of cucurbitacin C, a novel natural product from cucumber.

Corrigendum: In vitro and in vivo antitumor activity of cucurbitacin C, a novel natural product from cucumber.

Journal: Frontiers in pharmacology

Published: November 08, 2023

The inhibition of YTHDF3/m6A/LRP6 reprograms fatty acid metabolism and suppresses lymph node metastasis in cervical cancer.

The inhibition of YTHDF3/m6A/LRP6 reprograms fatty acid metabolism and suppresses lymph node metastasis in cervical cancer.

Journal: International journal of biological sciences

Published: June 15, 2023

NAT10/ac4C/FOXP1 Promotes Malignant Progression and Facilitates Immunosuppression by Reprogramming Glycolytic Metabolism in Cervical Cancer.

NAT10/ac4C/FOXP1 Promotes Malignant Progression and Facilitates Immunosuppression by Reprogramming Glycolytic Metabolism in Cervical Cancer.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: April 28, 2023

Interferon-induced transmembrane protein-1 competitively blocks Ephrin receptor A2-mediated Epstein-Barr virus entry into epithelial cells.

Interferon-induced transmembrane protein-1 competitively blocks Ephrin receptor A2-mediated Epstein-Barr virus entry into epithelial cells.

Journal: Nature microbiology

Published: March 06, 2023

FOXD1-dependent RalA-ANXA2-Src complex promotes CTC formation in breast cancer.

FOXD1-dependent RalA-ANXA2-Src complex promotes CTC formation in breast cancer.

Journal: Journal of experimental & clinical cancer research : CR

Published: August 06, 2022

Correction to: OTOGL, a gelforming mucin protein, is nonessential for male germ cell development and spermatogenesis in mice.

Correction to: OTOGL, a gelforming mucin protein, is nonessential for male germ cell development and spermatogenesis in mice.

Journal: Reproductive biology and endocrinology : RB&E

Published: September 09, 2021

AXDND1, a novel testis-enriched gene, is required for spermiogenesis and male fertility.

AXDND1, a novel testis-enriched gene, is required for spermiogenesis and male fertility.

Journal: Cell death discovery

Published: August 10, 2021

Showing 1-12 of 28

Last Updated: 09/26/2026